optimed

Ettlingen, Germany Founded: 1995 • Age: 31 yrs Acquired By Westlake Partners
Medical devices are developed for interventional radiology and related fields.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors - Brand Intelligence

About optimed

optimed is a company based in Ettlingen (Germany) founded in 1995 was acquired by Westlake Partners in June 2017. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. optimed offers products and services including sinus-XL Stent System, sinus-Venous Stent System, Ureteral Stents, and Biliary Endoprostheses.

  • Headquarter Ettlingen, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Optimed Medizinische Instrumente Gmbh
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Westlake Partners

    (Jun 01, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of optimed

optimed offers a comprehensive portfolio of products and services, including sinus-XL Stent System, sinus-Venous Stent System, Ureteral Stents, and Biliary Endoprostheses.

Product name locked
Category locked
Primary

Stent systems are used for arterial vascular treatment.

Product name locked
Category locked
Locked

Venous stents are designed for specific venous diseases.

Product name locked
Category locked
Locked

Ureteral stents are provided for fluid drainage solutions.

Product name locked
Category locked
Locked

Endoprostheses are offered for biliary fluid drainage procedures.

Funding Insights of optimed

Premium access

Detailed funding history for optimed

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in optimed

optimed has secured backing from 1 investor. Prominent investors backing the company include Westlake Partners.

All
Investor Description Founded Year Domain Location
Westlake Partners is engaged in investment and growth strategies for companies.
Locked Locked Locked
Premium access

Investor details for optimed

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by optimed

Investments
Premium access

Investment portfolio details for optimed

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - optimed

Premium access

Detailed financials for optimed

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Optimed Comparisons

optimed Primary company
Description
Medical devices are developed for interventional radiology a...
Location
Ettlingen, Germany
Founded Year
1995
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for optimed

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of optimed

Premium access

Detailed competitors of optimed

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Optimed

Premium access

Complete news archive for optimed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about optimed

optimed was founded in 1995.

optimed is headquartered in Ettlingen, Germany. It is registered at Ettlingen, Baden-wurttemberg, Germany.

Research, development, and production of medical devices are conducted by optimed for minimally invasive therapies. Focus is placed on vascular interventions, urology, gastroenterology, and special products. Solutions are provided for arterial and venous diseases, fluid drainage, and endoscopic procedures. Based in Ettlingen, Germany, operations are supported by a global sales network spanning over 70 countries. Innovation is driven by German technology to enhance patient care and improve quality of life worldwide.

optimed offers sinus-XL Stent System, sinus-Venous Stent System, Ureteral Stents, and Biliary Endoprostheses.

optimed has 1 investor. Key investors include Westlake Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available